In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....